These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 9457225)
1. Effect of thromboxane synthetase inhibitor on non-heart-beating donors in rat orthotopic liver transplantation. Soejima Y; Yanaga K; Nisizaki T; Yoshizumi T; Uchiyama H; Sugimachi K Surgery; 1998 Jan; 123(1):67-72. PubMed ID: 9457225 [TBL] [Abstract][Full Text] [Related]
2. Protective effect of FK506 and thromboxane synthase inhibitor on ischemia-reperfusion injury in non-heart-beating donor in rat orthotopic liver transplantation. Sasaki K; Miyake H; Kinoshita T; Ikeyama S; Tashiro S J Med Invest; 2004 Feb; 51(1-2):76-83. PubMed ID: 15000260 [TBL] [Abstract][Full Text] [Related]
3. The effects of thromboxane A2 synthetase inhibitor (OKY-046) on complete hepatic ischemia in rats with obstructive jaundice. Takahashi T Surg Today; 1996; 26(1):15-20. PubMed ID: 8680115 [TBL] [Abstract][Full Text] [Related]
4. The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury. Isozaki H; Okajima K; Hara H; Kobayashi M Surg Today; 1994; 24(5):435-40. PubMed ID: 8054815 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model. Garvin PJ; Niehoff ML; Robinson SM; Heisler T; Salinas-Madrigal L; Contis J; Solomon H Transplantation; 1996 May; 61(10):1429-34. PubMed ID: 8633364 [TBL] [Abstract][Full Text] [Related]
6. Hemodynamic analysis of post-reperfusion syndrome and the effect of preventing this syndrome using thromboxane A2 synthetase inhibitor (OKY-046) in swine liver transplantation. Ishine N; Yagi T; Ishikawa T; Sasaki H; Nakagawa K; Tanaka N Transplant Proc; 1997; 29(1-2):378-81. PubMed ID: 9123045 [No Abstract] [Full Text] [Related]
7. Liberation of vasoactive substances and its prevention with thromboxane A2 synthase inhibitor in pig liver transplantation. Yokoyama I; Kobayashi T; Negita M; Hayashi S; Yasutomi M; Katayama A; Uchida K; Takagi H Transpl Int; 1996; 9(1):76-81. PubMed ID: 8748415 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of TXA synthesis with OKY-046 improves liver preservation by prolonged hypothermic machine perfusion in rats. Xu H; Lee CY; Clemens MG; Zhang JX J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e212-20. PubMed ID: 17645480 [TBL] [Abstract][Full Text] [Related]
9. Involvement of thromboxane A2-thromboxane A2 receptor system of the hepatic sinusoid in pathogenesis of cold preservation/reperfusion injury in the rat liver graft. Ishiguro S; Arii S; Monden K; Fujita S; Nakamura T; Niwano M; Harada T; Ushikubi F; Narumiya S; Imamura M Transplantation; 1995 Apr; 59(7):957-61. PubMed ID: 7709455 [TBL] [Abstract][Full Text] [Related]
10. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats. Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452 [TBL] [Abstract][Full Text] [Related]
11. Endothelin antagonist treatment for successful liver transplantation from non-heart-beating donors. Fukunaga K; Takada Y; Taniguchi H; Mei G; Seino KI; Yuzawa K; Otsuka M; Todoroki T; Goto K; Fukao K Transplantation; 1999 Jan; 67(2):328-32. PubMed ID: 10075603 [TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of thromboxane A2 synthetase inhibitor on cold-stored rat liver. Suehiro T; Yanaga K; Itasaka H; Kishikawa K; Shirabe K; Sugimachi K Transplantation; 1994 Oct; 58(7):768-73. PubMed ID: 7940709 [TBL] [Abstract][Full Text] [Related]
13. Organ preserving effect of lidocaine administration in the model of orthotopic liver transplantation from non-heart-beating donors. Kusano T; Shiraishi M; Miyaguni T; Hara J; Muto Y Transplant Proc; 1996 Jun; 28(3):1928-9. PubMed ID: 8658950 [No Abstract] [Full Text] [Related]
14. Protective effects of L-arginine against ischemia-reperfusion injury in non-heart beating rat liver graft. Gong J; Lao XJ; Zhang SJ; Chen S Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):481-4. PubMed ID: 18842493 [TBL] [Abstract][Full Text] [Related]
15. Effects of thromboxane A2 synthesis inhibitor (OKY-046) on total liver ischemia in rats. Kobayashi T; Esato K; Morita N; Noshima NS Int Surg; 1996; 81(2):115-8. PubMed ID: 8912073 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of thromboxane A2 activity during warm ischemia of the liver. Shirabe K; Kin S; Shinagawa Y; Chen S; Payne WD; Sugimachi K J Surg Res; 1996 Feb; 61(1):103-7. PubMed ID: 8769950 [TBL] [Abstract][Full Text] [Related]
17. Effect of thromboxane A2 synthetase inhibitor on metabolism and contractility in ischemic reperfused rabbit heart. Kawabata H; Ryomoto T; Katori R Angiology; 1997 Aug; 48(8):689-97. PubMed ID: 9269138 [TBL] [Abstract][Full Text] [Related]
18. Experimental study of a type 3 phosphodiesterase inhibitor on liver graft function. Ikegami T; Nishizaki T; Hiroshige S; Ohta R; Yanaga K; Sugimachi K Br J Surg; 2001 Jan; 88(1):59-64. PubMed ID: 11136311 [TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of donor pretreatment with thromboxane A2 synthase inhibitor on the graft survival in pig liver transplantation. Yokoyama I; Negita M; Kobayashi T; Hayashi S; Hachisuka T; Sato E; Orihara A; Uchida K; Takagi H J Surg Res; 1996 Jan; 60(1):232-8. PubMed ID: 8592420 [TBL] [Abstract][Full Text] [Related]
20. Thromboxane A2 in preservation-reperfusion injury: the effect of thromboxane A2 synthetase inhibitor. Suehiro T; Yanaga K; Itasaka H; Kishikawa K; Shirbe K; Shimada M; Sugimachi K J Surg Res; 1996 May; 62(2):216-23. PubMed ID: 8632642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]